Skip to main content
# Title Department Research Year
161 Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity Department of Pharmaceutical Organic Chemistry 2022
162 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
163 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022
164 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
165 Selective Targeting of the Novel CK-10 Nanoparticles to the MDAMB- 231 Breast Cancer Cells Department of Industrial Pharmacy 2021
166 Charge-Transfer Complex of Linifanib with 2,3-dichloro-3,5-dicyano-1,4-benzoquinone: Synthesis, Spectroscopic Characterization, Computational Molecular Modelling and Application in the Development of Novel 96-microwell Spectrophotometric Assay 2021
167 Ivermectin detection using Ag@ B, S co-doped reduced graphene oxide nanohybrid Department of Pharmaceutical Analytical Chemistry 2021
168 A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue Department of Pharmaceutics 2021
169 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
170 Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia 2021